Thus, with the list of associated gene mutations evolving, more women can be expected to carry some mutation pre-disposing them to ovarian cancer and overall will exceed the 15% of all ovarian cancers attributed to BRCA1 and BRCA2 [46]. The gene discussed is BRCA2; the disease is ovarian carcinoma.